Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19,
Continue reading »
Home » type
Welcome news for pregnant women with type 2 diabetes
A world-first, international study of a common treatment for women with Type 2 diabetes, has found that the drug may
Continue reading »
More than one drink a day may raise high blood pressure risk in adults with type 2 diabetes
Drinking eight or more alcoholic beverages a week may increase the risk of high blood pressure (also called hypertension) among
Continue reading »
Artificial pancreas effectively controls type 1 diabetes in children age 6 and up
A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which
Continue reading »
Biological ‘atlas’ shows dual personality for immune cells that cause Type 1 diabetes
Immunologists at St. Jude Children’s Research Hospital have created a database that identifies gene-regulatory mechanisms in immune cells that facilitate
Continue reading »
New clues to the link between ALS and type 2 diabetes
Patients with ALS (amyotrophic lateral sclerosis) often suffer from type 2 diabetes. This phenomenon has long remained mechanistically enigmatic. Now,
Continue reading »
Unexpected viral behavior linked to type 1 diabetes in high-risk children
New results from The Environmental Determinants of Diabetes in the Young (TEDDY) study show an association between prolonged enterovirus infection
Continue reading »
New type of drug might ease migraines
(HealthDay)—Migraine sufferers who cannot get relief from existing medications may soon have a novel treatment option, a new trial suggests.
Continue reading »
New evidence supports surgery for rare type of brain lymphoma
Through a systematic review of published studies going back 50 years, Johns Hopkins Medicine researchers say they have identified a
Continue reading »
A new molecule to improve treatment for type 2 diabetes and non-alcoholic fatty liver disease
A new molecule, EPB-53, could help fight type 2 diabetes and non-alcoholic fatty liver disease, according to a new study
Continue reading »